Drugs / RBI-4000
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06048770 | Sep 2023 → Jul 2024 | — | Replicate Bioscience | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RBI-4000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06048770 ↗ |
| Route | Intramuscular | “RBI-4000 administered at various dose levels via intramuscular injection” NCT06048770 ↗ |